Kristin Yarema

2023

In 2023, Kristin Yarema earned a total compensation of $2.4M as President, Cell Therapy at Poseida Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$171,280
Option Awards$934,210
Salary$380,625
Stock Awards$934,910
Other$13,540
Total$2,434,565

Yarema received $934.9K in stock awards, accounting for 38% of the total pay in 2023.

Yarema also received $171.3K in non-equity incentive plan, $934.2K in option awards, $380.6K in salary and $13.5K in other compensation.

Rankings

In 2023, Kristin Yarema's compensation ranked 406th out of 2,912 executives tracked by ExecPay. In other words, Yarema earned more than 86.1% of executives.

ClassificationRankingPercentile
All
406
out of 2,912
86th
Division
Manufacturing
232
out of 1,602
86th
Major group
Chemicals And Allied Products
163
out of 901
82nd
Industry group
Drugs
160
out of 864
82nd
Industry
Biological Products, Except Diagnostic Substances
57
out of 211
73rd
Source: SEC filing on April 25, 2024.

Yarema's colleagues

We found two more compensation records of executives who worked with Kristin Yarema at Poseida Therapeutics in 2023.

2023

Mark Gergen

Poseida Therapeutics

Chief Executive Officer

2023

Brent Warner

Poseida Therapeutics

President, Gene Therapy

News

You may also like